Interleukin-12p40 Deficiency Attenuates Myocardial Ferroptosis in Doxorubicin-Induced Chronic Cardiomyopathy by Inhibiting Th17 Differentiation and Interleukin-17A Production
Academic Background Doxorubicin (Dox) is an anthracycline drug widely used in the treatment of tumors, but it exhibits dose-dependent cardiotoxicity, potentially leading to cardiomyopathy and heart failure. Despite its significant anticancer effects, the cardiotoxicity of Dox limits its clinical application. Currently, Dexrazoxane is the only FDA-a...